• Home
  • Serum CA19-9 decline compared to radiographic response as a surrogate for clinical outcomes in patients with metastatic pancreatic cancer receiving chemotherapy.

Serum CA19-9 decline compared to radiographic response as a surrogate for clinical outcomes in patients with metastatic pancreatic cancer receiving chemotherapy.

Author List
Wong D, Ko AH, Hwang J, Venook AP, Bergsland EK, Tempero MA
Publication
Pancreas
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1463942
Publication Year
2008
PubMed ID
18815548
Publication Title
Wong D, Ko AH, Hwang J, Venook AP, Bergsland EK, Tempero MA. Serum CA19-9 decline compared to radiographic response as a surrogate for clinical outcomes in patients with metastatic pancreatic cancer receiving chemotherapy. Pancreas. 2008 Oct; 37(3):269-74.